Logo

InterVenn Biosciences: Erwin Estigarribia, Laura Beggrow

Jan 05, 2023

InterVenn Biosciences has appointed Erwin Estigarribia its CEO and Laura Beggrow its chief commercial officer. Estigarribia was previously Intervenn's president and chief operating officer, and prior to joining the company, he held executive level positions at Nugen, CardioDX, and Applied Proteomics. Beggrow previously held executive leadership positions at HTG Molecular, Celcuity, NantHealth, and Strand Diagnostics. She was also VP of sales and diagnostics at Genomic Health from 2004 to 2013.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.